Cargando…

2023 GEIS Guidelines for gastrointestinal stromal tumors

Gastrointestinal stromal tumor (GIST) is the most common malignant neoplasm of mesenchymal origin. GIST spans a wide clinical spectrum that ranges from tumors with essentially no metastatic potential to malignant and life-threatening spread diseases. Gain-of-function mutations in KIT or PDGFRA recep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Serrano, César, Martín-Broto, Javier, Asencio-Pascual, José Manuel, López-Guerrero, José Antonio, Rubió-Casadevall, Jordi, Bagué, Silvia, García-del-Muro, Xavier, Fernández-Hernández, Juan Ángel, Herrero, Luís, López-Pousa, Antonio, Poveda, Andrés, Martínez-Marín, Virginia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467260/ https://www.ncbi.nlm.nih.gov/pubmed/37655207 http://dx.doi.org/10.1177/17588359231192388

Ejemplares similares

GEIS 2013 guidelines for gastrointestinal sarcomas (GIST)
por: Poveda, Andrés, et al.
Publicado: (2014)

Phosphorylated-insulin growth factor I receptor (p-IGF1R) and metalloproteinase-3 (MMP3) expression in advanced gastrointestinal stromal tumors (GIST). A GEIS 19 study
por: Maurel, Joan, et al.
Publicado: (2016)

SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022)
por: Serrano, César, et al.
Publicado: (2023)

Malignant bone tumors (other than Ewing’s): clinical practice guidelines for diagnosis, treatment and follow-up by Spanish Group for Research on Sarcomas (GEIS)
por: Redondo, Andrés, et al.
Publicado: (2017)

GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)
por: Mora, J, et al.
Publicado: (2017)

Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS)
por: Garcia del Muro, Xavier, et al.
Publicado: (2015)

A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study
por: Martínez-Trufero, Javier, et al.
Publicado: (2021)

Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study
por: López-Pousa, A, et al.
Publicado: (2006)

Prognostic Impact of let-7e MicroRNA and Its Target Genes in Localized High-Risk Intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) Study
por: Fernandez-Serra, Antonio, et al.
Publicado: (2020)

Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups
por: Gronchi, Alessandro, et al.
Publicado: (2019)

CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study
por: Moura, David S., et al.
Publicado: (2020)

Updated Review and Clinical Recommendations for the Diagnosis and Treatment of Patients with Retroperitoneal Sarcoma by the Spanish Sarcoma Research Group (GEIS)
por: Álvarez Álvarez, Rosa, et al.
Publicado: (2023)

REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial
por: Martin-Broto, Javier, et al.
Publicado: (2023)

Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib
por: Joensuu, Heikki, et al.
Publicado: (2017)

Phase II Clinical Trial With Pegylated Liposomal Doxorubicin (CAELYX®/Doxil®) and Quality of Life Evaluation (EORTC QLQ-C30) in Adult Patients With Advanced Soft Tissue Sarcomas: A study of the Spanish Group for Research in Sarcomas (GEIS)
por: Poveda, A., et al.
Publicado: (2005)

Phase II Trial of Doxorubicin Plus Escalated High-Dose Ifosfamide in Patients With Advanced Soft Tissue Sarcomas of the Adult: A Study of the Spanish Group for Research on Sarcomas (GEIS)
por: López-Pousa, A., et al.
Publicado: (2006)

Capacity-building efforts by the AFHSC-GEIS program
por: Sanchez, Jose L, et al.
Publicado: (2011)

Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study
por: Jongsma, Hannah E., et al.
Publicado: (2017)

Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors
por: Serrano, César, et al.
Publicado: (2020)

Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS)
por: Pérez-Fidalgo, Jose Alejandro, et al.
Publicado: (2023)

Antimicrobial resistance surveillance in the AFHSC-GEIS network
por: Meyer, William G, et al.
Publicado: (2011)

Gene expression analyses determine two different subpopulations in KIT-negative GIST-like (KNGL) patients
por: Moura, David S., et al.
Publicado: (2018)

Evidence mapping based on systematic reviews of therapeutic interventions for gastrointestinal stromal tumors (GIST)
por: Ballesteros, Mónica, et al.
Publicado: (2017)

Nivolumab-Induced Autoimmune Haemolytic Anaemia and Safety of Subsequent Use of Ipilimumab: A Case Report
por: Carbó-Bagué, Anna, et al.
Publicado: (2021)

Migration history and risk of psychosis: results from the multinational EU-GEI study
por: Tarricone, Ilaria, et al.
Publicado: (2022)

Optimization of the Therapeutic Approach to Patients with Sarcoma: Delphi Consensus
por: Álvarez Álvarez, Rosa, et al.
Publicado: (2019)

Giant cell tumour of bone: new treatments in development
por: López-Pousa, A., et al.
Publicado: (2015)

A growing global network’s role in outbreak response: AFHSC-GEIS 2008-2009
por: Johns, Matthew C, et al.
Publicado: (2011)

High-risk gastrointestinal stromal tumour (GIST) and synovial sarcoma display similar angiogenic profiles: a nude mice xenograft study
por: Giner, Francisco, et al.
Publicado: (2017)

Evolution of the Autism Literature and the Influence of Parents: A Scientific Mapping in Web of Science
por: Carmona-Serrano, Noemí, et al.
Publicado: (2021)

Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study
por: Quattrone, Diego, et al.
Publicado: (2019)

Synergistic effects of childhood adversity and polygenic risk in first-episode psychosis: the EU-GEI study
por: Aas, Monica, et al.
Publicado: (2023)

A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors
por: Martin-Broto, Javier, et al.
Publicado: (2022)

Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study
por: D'Andrea, Giuseppe, et al.
Publicado: (2023)

Trabectedin therapy as an emerging treatment strategy for recurrent platinum-sensitive ovarian cancer
por: López-Guerrero, José Antonio, et al.
Publicado: (2015)

Dietary Intervention through Flipped Learning as a Techno Pedagogy for the Promotion of Healthy Eating in Secondary Education
por: López Núñez, Juan Antonio, et al.
Publicado: (2020)

Enteric disease surveillance under the AFHSC-GEIS: Current efforts, landscape analysis and vision forward
por: Money, Nisha N, et al.
Publicado: (2011)

Migration history, first episode psychosis and child abuse: Results from the EU-GEI study
por: Tarricone, I., et al.
Publicado: (2021)

Jumping to conclusions, general intelligence, and psychosis liability: findings from the multi-centre EU-GEI case-control study
por: Tripoli, Giada, et al.
Publicado: (2021)

The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study
por: Ferraro, Laura, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f0rh3hacrgnklnhh759h2dqdel